Literature DB >> 23071161

High frequency of HLA B62 in fulminant type 1 diabetes with the drug-induced hypersensitivity syndrome.

Hiroshi Onuma1, Mikiko Tohyama, Akihisa Imagawa, Toshiaki Hanafusa, Tetsuro Kobayashi, Yoko Kano, Jun Ohashi, Koji Hashimoto, Haruhiko Osawa, Hideichi Makino.   

Abstract

CONTEXT: Fulminant type 1 diabetes (FT1D) is a subtype of type 1 diabetes characterized by an extremely abrupt onset. FT1D cases associated with the drug-induced hypersensitivity syndrome (DIHS) have recently been reported.
OBJECTIVE: The clinical characteristics of FT1D associated with DIHS were investigated in this study.
METHODS: Case reports of FT1D associated with DIHS in Japanese subjects were collected and analyzed by means of a questionnaire to the authors. A nationwide questionnaire survey was administered to dermatology specialists, concerning the frequency of FT1D associated with DIHS.
RESULTS: In 15 case reports, the mean age at onset of FT1D was 53.4 yr and the mean time for its development from the onset of DIHS was 39.9 d. A higher frequency of human leukocyte antigen (HLA) B62, but not of HLA DR was found in FT1D with DIHS than that for cases without DIHS (P < 0.001). The reactivation of herpes virus 6 and cytomegalovirus was detected in 11 and four cases, respectively. Among 746 patients with DIHS in the nationwide survey, four developed FT1D during a 3-yr period. The frequency of FT1D in DIHS (0.54%) was much higher than that in the general Japanese population (0.010%).
CONCLUSIONS: The clinical characteristics of FT1D with DIHS were similar to those without DIHS except for the high frequency of HLA B62, which may be involved in the pathogenesis of FT1D with DIHS. Because the frequency was much higher than that in the general Japanese population, FT1D should be kept in mind when DIHS develops.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23071161     DOI: 10.1210/jc.2012-2054

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

Review 1.  Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): An Interplay among Drugs, Viruses, and Immune System.

Authors:  Yung-Tsu Cho; Che-Wen Yang; Chia-Yu Chu
Journal:  Int J Mol Sci       Date:  2017-06-09       Impact factor: 5.923

2.  Drug-induced hypersensitivity reaction: A case of simultaneous thyroiditis and fulminant type 1 diabetes.

Authors:  Michael Marchese; Matthew Leinung; Hassan Shawa
Journal:  Avicenna J Med       Date:  2017 Apr-Jun

3.  Co-Occurrence of Multiple Endocrine Abnormalities Induced by the DIHS/DRESS.

Authors:  Mingqun Deng; Han Wu; Miao Yu; Yi Tian; Yuxiu Li; Xinhua Xiao
Journal:  Int J Endocrinol       Date:  2019-10-03       Impact factor: 3.257

4.  Risk factors for sudden death and cardiac arrest at the onset of fulminant type 1 diabetes mellitus.

Authors:  Megu Yamaguchi Baden; Akihisa Imagawa; Hiromi Iwahashi; Iichiro Shimomura; Takuya Awata; Hiroshi Ikegami; Yasuko Uchigata; Haruhiko Osawa; Hiroshi Kajio; Eiji Kawasaki; Yumiko Kawabata; Akira Shimada; Kazuma Takahashi; Shoichiro Tanaka; Kazuki Yasuda; Hisafumi Yasuda; Tetsuro Kobayashi; Toshiaki Hanafusa
Journal:  Diabetol Int       Date:  2015-12-29

Review 5.  Severe Delayed Drug Reactions: Role of Genetics and Viral Infections.

Authors:  Rebecca Pavlos; Katie D White; Celestine Wanjalla; Simon A Mallal; Elizabeth J Phillips
Journal:  Immunol Allergy Clin North Am       Date:  2017-11       Impact factor: 3.479

6.  Fulminant type 1 diabetes in the course of Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome.

Authors:  Danièle Dubois-Laforgue; Laurence Moachon; Hélène Laude; José Timsit
Journal:  Diabetes Care       Date:  2013-05       Impact factor: 19.112

Review 7.  Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012.

Authors:  Sheena N Ramasamy; Cameron S Korb-Wells; Diluk R W Kannangara; Myles W H Smith; Nan Wang; Darren M Roberts; Garry G Graham; Kenneth M Williams; Richard O Day
Journal:  Drug Saf       Date:  2013-10       Impact factor: 5.228

8.  Onset of fulminant type 1 diabetes mellitus under immunotolerance status after long-term therapy for chronic inflammatory demyelinating polyneuropathy.

Authors:  Ryo Shigemoto; Takatoshi Anno; Eiichi Ohnuki; Satoru Kosaka; Niro Okimoto; Kohei Kaku; Hideaki Kaneto
Journal:  J Diabetes Investig       Date:  2018-06-15       Impact factor: 4.232

9.  A rare case of fulminant type 1 diabetes mellitus accompanied by both acute pancreatitis and myocarditis - case report.

Authors:  Fujiko Egashira; Midori Kawashima; Ai Morikawa; Minami Kosuda; Hisamitsu Ishihara; Kentaro Watanabe
Journal:  BMC Endocr Disord       Date:  2020-08-18       Impact factor: 2.763

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.